Memorandum 19
Submission from GlaxoSmithKline
INTRODUCTION
1. GSK welcomes the Science and Technology
Committee's Inquiry into the Funding of Science and Discovery
Centres and looks forward to the outcomes of the Inquiry. We welcome
also the increasing recognition in the UK of the need to engage
and attract young people to science subjects and scientific careers
and we hope that the inquiry develops further information on how
this might best be achieved.
2. GSK notes that the inquiry will focus
upon the role science centres play in the attraction of young
people to science and the funding available to such centres from
a variety of sources. The broader context however of science education
and the engagement of young people in science related subjects
should not be ignored.
3. This submission focuses on the experience
we have had thus far in interacting with science and discovery
centres and how this fits into our broader science education strategy
and the activities encompassed within this. In addition, we provide
comment regarding the current situation whereby science centres
in England lack clear departmental sponsorship and may also lack
access to sustainable funding.
INTRODUCTION TO
GLAXOSMITHKLINE
4. The pharmaceutical industry makes a significant
contribution to the health and wealth of UK citizens by employing
and developing highly skilled workforces, investment in research
and development, healthy working populations, efficiencies in
healthcare system, and exports to the rest of the world. In the
UK alone, the pharmaceutical industry contributes over £3
billion a year to research and development and employs over 80,000
people in R&D, manufacturing and other related activities.
5. GSK is one of the world's leading research-based
pharmaceutical and healthcare companies. The company's mission
is to improve the quality of human life by enabling people to
do more, feel better and live longer. We are involved in the research,
development, manufacture and commercialisation of prescription
pharmaceuticals, vaccines, over-the-counter medicines, and health-related
consumer products.
6. In 2006, GSK invested £3.5 billion
in R&D globally and the UK benefited from £1.3 billion
of this, making us the single largest private sector funder of
R&D in the UK. Globally, our R&D organisation employs
almost 15,000 people, with nearly 6,000 of those employed in the
UK, where we have nine R&D sites. Collaborative research plays
a key role in this investment with GSK engaging in multiple partnerships
and knowledge transfer activities with a variety of academic and
industry partnerships.
7. GSK's continued investment in the UK
will depend on the quality of the graduates and postgraduates
and upon the maintenance of the quality of the basic research
carried out in the many universities with which we collaborate.
The UK science base is strong; however, scope exists to improve
its quality, particularly in light of the increasingly mobile
nature of investment by the sector. It is therefore in the best
interests of all stakeholderspatients, researchers, government
and industrythat the science and technology skills available
to the pharmaceutical industry in the UK remain strong and the
engagement and teaching of young people is critical to this.
8. We ourselves are committed to ensuring
that young people are engaged in science related subjects and
our science education strategy has as its vision "to cultivate
communities in which people understand the value that science
brings to their lives and believe that learning about science
is important". As such our science education programmes aim
to develop:
motivated students that have a strong
understanding of science and scientific processes;
a diverse pool of talented students
to recruit into science careers;
a public that is equipped to make
sound decisions and engage in dialogue about science issues; and
GSK's reputation as a leader in science
and technology.
9. Further information about our science
education strategy and criteria for programme support can be found
at Annex One.
GSK INTERACTION WITH
SCIENCE AND
DISCOVERY CENTRES
10. GSK has a range of projects we are currently
undertaking with science museums and science and discovery centres
as we believe they can play an important role in generating interest
in young people in science subjects and related careers through
a range of alternative activities and projects. The principal
projects in which we are involved, however, have not yet been
launched and therefore their impact has not been able to be measured.
However we are confident that they represent innovative and valuable
ways of reaching out to young people and engaging them in science
related issues and activities.
The Darwin Centre, Natural History Museum
11. As part of our science education strategy,
GSK donated £1 million to Phase 2 of the Darwin Centre at
the Natural History Museum, which will be launched in 2009. This
is a new and unique Life Sciences complex which will be adjacent
to the Museum's main Waterhouse building at the western end of
the site. It aims to deliver three main benefits to the nation:
safeguard the world's finest scientific
collection of 54 million animals and plants by replacing antiquated
and insecure storage accommodation with 28,000 sq. metres of modern
purpose built facilities;
help raise the percentage of the
Museum's collection on public display to 75%the first time
that a scientific research institution will be put on display
in this way; and
create a modern, high quality facility
for over 250 Museum scientists and for thousands of visiting professional
scientists from the UK and around the world who use the Museum's
collections.
12. The Darwin Centre will not only be a
first rate facility for scientists but also be an inspiring place
for young people and adults. One of its main aims is to revolutionise
the public's understanding of the natural world, by allowing unprecedented
physical and electronic access to the widest variety of animal
and plant species ever assembled. To support this level of access,
the Darwin Centre will have an innovative, interactive public
education programmethe "Encounter Programme".
13. The "Encounter Programme"
will be a new mechanism for bringing scientists and their work
into closer contact with the general public and students. The
programme will promote public understanding of science, convey
its investigative nature and highlight it as a cultural and vocational
activity. All of the explorations will aim to improve the public's
appreciation of science, breakdown barriers between scientist
and layperson and advocate public participation in science decision
making.
14. To ensure that good educational theory
is applied to the practice of managing the Darwin Centre's "Encounter
Programme", a team of dedicated educational researchers will
liaise with project managers at all stages of development. Through
developmental research, continual programme evaluation and by
analysing feedback from participating scientists and visitors
(both real and virtual) they will investigate the effectiveness
of the "Encounter Programme's" approach.
15. Despite the highly acclaimed and valued
research work, which takes place at the Museum, current storage
arrangements limit access for scientific research. Many of the
facilities needed in a modern laboratory are difficult to set
up in a Grade 1 listed building. Public demands of science and
scientists are becoming more sophisticated. Deference is giving
way to a more questioning attitude, driven by concerns for issues
such as environmental degradation, reduction in biological diversity,
genomics, genetically modified organisms and other biotechnologies.
The Museum has a crucial role to play in this shift in public
reaction to science. It aims to encourage a more enquiring attitude
to science and the natural world and use this to promote self-directed
learning.
16. Visitors will have the chance to go
"Behind the Scenes" and meet and interact with the scientists
who are working on conservation, biodiversity and systematics
projects and will hear about how their work is vital for the survival
and control of the natural world.
Centre of the Cell, Whitechapel
17. GSK is also supporting the Centre of
the Cella unique science education project to help children
and young people learn about cell biology and inspire them to
study science and take up careers in biomedical science. The Centre,
which will open in Spring 2008, is based at Queen Mary's School
of Medicine and Dentistry in Whitechapel, and is the first science
education centre in the world to be sited inside the research
laboratories of a major medical school.
18. The Centre of the Cell will engage young
people through an innovative mix of interactive, theatrical and
multimedia experiences to cover the basics of cells and organs
and how medical research is carried out. It will also enable debate
about ethical issues within the biosciences including cloning,
stem cells, animal experimentation, and pre-implantation genetic
diagnosis. These experiences will help young people understand
that:
the cells in your body work together
to keep you healthy and that when you are ill your "cells
have gone wrong". Scientists at Queen Mary and around the
world are trying to find new ways of "putting cells right";
and
the work that scientists are doing
at Queen Mary and in other similar research centres raise ethical
questions that need to be discussed.
19. The Centre's "Pod" is based
on a 16 cell embryo and is suspended above the labs, enabling
young people to see scientists at work below. Once in the "Pod",
young people will learn about cells through four integrated components:
the nucleus of the cell which contains interactive games; perimeter
screens with digital interactives; a website with extended content,
including interactives from the perimeter screens and videos of
science and scientists; and audio-visual experiences projected
onto the walls of the "Pod". A virtual tour of the "Pod"
can be seen at: www.centreofthecell.org.
20. The target audience is students aged
9 to 16 from all London boroughs, in particular local schools
in the London Borough of Tower Hamlets. Visits from schools will
be free of charge with visits from local schools, which are in
an area of deprivation, being funded by businesses in Canary Wharf
and the City. In addition, evening visits will be allocated to
after-school clubs, youth and community groups, whilst at weekends
and during school holidays the Centre will be open to the general
public, focusing on young people and their families. It is anticipated
that demand will outstrip the 32,000 school places available annually
and also that young people nationally and internationally will
also benefit from resources made available on the Centre of the
Cell's.
Other interactions
21. GSK is also in discussion with science
centres elsewhere in the UK who have approached us regarding outreach
activities to schools. This would potentially enable us to extend
our support beyond London and reach young people who are not able
to visit science centres due to constraints such as income or
location. Findings from this Inquiry will help inform discussions
with these centres.
SUPPORT FOR
SCIENCE AND
DISCOVERY CENTRES
22. There are important elements that GSK
seeks when partnering with any group in relation to science education
activities. These include:
alignment with the aims of GSK's
science education strategy and criteria for support (as at Annex
One);
that they fit into the portfolio
of methods that GSK supports to engage young people in science
and develop their understanding of science;
that young people are led through
the learning experience and activities by appropriately qualified
and trained staff to ensure that their understanding of the science
topic or concept is maximised and the `hands-on, brains-off' syndrome
is avoided;
Science Centres that are accessible
to young people from all backgrounds. Even if entry to centres
is free of charge, travel costs may prevent young people from
low income backgrounds and rural areas from visiting centres.
Outreach programmes that visit schools are therefore extremely
helpful;
teacher materials and ideally training
need to be made available prior to visits to enable teachers to
prepare their students for the visit and to maximise effective
follow-up; and
independent evaluation of projects
and activities are undertaken.
23. The Centre of the Cell's approachas
outlined belowclosely matches these criteria, for example,
as:
it is based in research laboratories,
so visiting young people can actually see scientists at work,
raising their awareness of careers beyond those they are traditionally
aware of such as medicine, veterinary science, forensic science
and so forth;
the Centre conducted research with
local young people to find out what they wanted to know about
cell biology, and designed the content using contexts suggested
by young people, rather than deciding on the content and then
piloting it with young people. This also links to the National
Curriculum;
young people will be led through
the learning experience by staff at the centre;
the Centre is based in an area of
significant deprivation with the cost of visits for local students
being met by by city financial institutions;
research scientists will support
visits by students, again raising their awareness of careers;
the Centre website will enable information
and activities on cell biology to be accessed by broader audiences
than simply those students visiting the Centre; and
the Centre will make material available
to teachers via their website, allowing effective preparation
for students' visits, and are considering trialing pre-visit training
for local teachers to ensure that they possess the scienctific
knowledge they need to prepare their students.
SPONSORSHIP OF
SCIENCE AND
DISCOVERY CENTRES
AND ACCESS
TO SUSTAINABLE
FUNDING
24. Currently, in England, no government
department has clear responsibility for science centres and their
strategic development and support. GSK would recommend that this
situation be addressed and one department given clear accountability
for ensuring that centres are well managed and well run. That
department should also work to deliver good coverage of science
and discovery centres across England and that young people around
the country do not lack access to either the centres themselves
or outreach programmes being run by those centres.
25. Linked to this is the situation whereby
centres cannot at present bid for particular government grants
and funding in order to ensure sustainable funding streams into
the future. Considering the considerable investment made in these
centres by both the charitable and business sectors, this situation
needs to be addressed if investments, such as those outlined above,
are not to run the risk of being squandered. Whilst we are not
necessarily advocating that the funding mechanism for science
and discovery centres should mirror exactly those available to
museums, some sustainable form of funding should be made available
to them.
June 2007
|